Aggressive B-cell Lymphoma
📧 Sign up to get email alerts when something new happens for Aggressive B-cell Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: Mosunetuzumab Consolidation Therapy After autoSCT in r/r Aggressive B Cell Lymphoma [Phase 1]
Phase 1 clinical trial evaluating mosunetuzumab consolidation after autologous stem cell transplantation in relapsed/refractory aggressive B…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Proof of Concept for Real-time Multicentric Monitoring of MRD by PET and ctDNA in Aggressive B-Cell Lymphomas
A multicenter, proof-of-concept trial investigating real-time monitoring of minimal residual disease in aggressive B-cell lymphomas using PE…
-
CLINICAL_TRIALS trial_result · 2026-03-27Clinical Trial Update: Axi-Cel as a 2nd Line Therapy in Patients With Relapsed/Refractory Aggressive B Lymphoma Ineligible to Autologous Stem Cell Transplantation [Phase 2]
A Phase 2 clinical trial evaluates axicabtagene ciloleucel as second-line therapy for relapsed/refractory aggressive B-cell lymphoma in pati…
-
CLINICAL_TRIALS research · 2026-02-02Clinical Trial Update: A Study to Learn How Safe and Tolerable Odronextamab and Cemiplimab Are in Adult Patients With B-cell Malignancies [Phase 1]
A Phase 1 clinical trial update evaluating the safety and tolerability of odronextamab in combination with cemiplimab in adults with relapse…
-
CLINICAL_TRIALS trial_result · 2026-01-29Clinical Trial Update: Acalabrutinib + Liso-Cel In R/R Aggressive B-Cell Lymphomas [Phase 2]
Phase 2 study evaluating acalabrutinib plus lisocabtagene maraleucel (Liso-Cel) in refractory/relapsed aggressive B-cell lymphomas, includin…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-12-03Clinical Trial Update: Early Palliative Care for Patients With Multiple Myeloma and Aggressive Lymphoma [NA]
Clinical trial update shows a study evaluating early palliative care for patients with multiple myeloma and aggressive lymphoma is currently…
-
CLINICAL_TRIALS research · 2025-09-22Clinical Trial Update: G-Pola-GemOx in Refractory/Relapsed Aggressive B-Cell Lymphoma [Phase 2]
Phase 2 trial of the G-Pola-GemOx regimen for refractory/relapsed aggressive B-cell lymphoma is not yet recruiting.